[{"name":"page-hero","instance":1,"visibility":["lg","md","sm"],"config":{"hero":{"enabled":true,"text":{"title":"Eczema Treatments ","desc":"Here is an overview of the different types of treatment methods and medications used to treat eczema. This includes daily skincare regimens like bathing and moisturizing to over-the-counter and prescription medications."},"image":{"alt":"","desktop":{"src":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatmentsHub_ImageTextHero-scaled-1370x470.jpg","src2x":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatmentsHub_ImageTextHero-scaled-2560x940.jpg","alignment":"center","width":1370,"height":470},"tabletLarge":{"src":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatmentsHub_ImageTextHero-scaled-960x470.jpg","src2x":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatmentsHub_ImageTextHero-scaled-1920x940.jpg","alignment":"center","width":960,"height":470},"tabletSmall":{"src":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatmentsHub_ImageTextHero-scaled-720x470.jpg","src2x":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatmentsHub_ImageTextHero-scaled-1440x940.jpg","alignment":"center","width":720,"height":470},"mobile":{"src":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatmentsHub_ImageTextHero-scaled-375x410.jpg","src2x":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatmentsHub_ImageTextHero-scaled-750x820.jpg","alignment":"center","width":375,"height":410}}},"feed":{"title":"","subtitle":"","link_text":"View All","link_url":"","items":[]}}},{"name":"wysiwyg","instance":1,"visibility":["lg","md","sm"],"config":{"wysiwyg":"\u003Ch2\u003ECurrent treatment options for eczema\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EIf you\u0027re seeking relief from eczema symptoms, you\u0027re not alone. Millions of people manage this chronic skin condition daily. While there\u0027s no cure, a variety of effective treatments can help you manage and prevent eczema flares. \u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EDepending on severity, managing eczema often involves a combination of lifestyle adjustments, daily management routines and medications to alleviate symptoms and prevent flares. These eczema treatments include: \u003C/span\u003E\u003C/p\u003E\n\u003Cul\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EBathing\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EMoisturizing\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EWet wrap therapy\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EPhototherapy\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EOver-the-counter medicines\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EPrescription topicals (creams, gels)\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EPrescription oral medicines (pills, liquid)\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EPrescription injectables (needle injections)\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EAlternative and complementary treatments \u003C/span\u003E\u003C/li\u003E\n\u003C/ul\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EThese are the go-to standard of care protocols for managing eczema that your doctor will discuss with you. By working with your healthcare provider, you can develop a treatment plan unique to you. Eczema affects everyone differently — what alleviates one person\u0027s symptoms might not work for another. Understanding your specific triggers and treatment responses is crucial. \u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about each treatment below and get more details about each one to help you understand your options.\u003C/span\u003E\u003C/p\u003E\n\u003Ch2\u003EBathing for eczema\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EPeople with eczema tend to have very dry skin in general. A skin barrier that is inflamed or dry is vulnerable to bacteria and allergens, which can make eczema symptoms worse. Taking a bath or shower is helpful for \u003C/span\u003E\u003Ca href=\u0022https://nationaleczema.org/types-of-eczema\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003Eeczema\u003C/span\u003E\u003C/a\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003E. It helps remove potential irritants from your skin (dust, pollen, etc.). Bathing with lukewarm water for a short period of time is recommended and immediately moisturizing after getting out of the shower or bath is a must to prevent drying out of the skin.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/bathing/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about bathing routines, oatmeal bath remedies, bleach bath treatments and more.\u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EMoisturizing for eczema\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EMoisturizers, including lotions, creams and ointments, help protect the outermost layer of skin known as the skin barrier. People with eczema have a damaged skin barrier, which makes their skin more sensitive to irritants and allergens. It’s important to understand how and when to properly moisturize and which products are best to use when you have eczema.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/moisturizing/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about the best moisturizing techniques to help manage eczema.\u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EWet wrap therapy\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EWet wrap therapy is a treatment for \u003C/span\u003E\u003Ca href=\u0022https://nationaleczema.org/types-of-eczema/\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003Eatopic dermatitis\u003C/span\u003E\u003C/a\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003E, the most common type of \u003C/span\u003E\u003Ca href=\u0022https://nationaleczema.org/eczema/\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003Eeczema\u003C/span\u003E\u003C/a\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003E. Doctors typically recommend wet wraps during severe eczema flares when there is severe pain or itch. Wet wrap therapy can help reduce itch and pain and provide some relief.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/wet-wrap-therapy/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about wet wraps for eczema, including how to do them and when you should use them.\u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EPhototherapy\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EPhototherapy, also called light therapy, is a treatment for eczema that uses specific wavelengths of ultraviolet (UV) light to reduce itch and inflammation. It is prescribed for various types of eczema but it is most often used for moderate to severe eczema.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/phototherapy/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about phototherapy, including how it works and what you can expect during a session.\u003C/span\u003E\u003C/i\u003E \u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EOver-the-counter medicines\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EOver-the-counter (OTC) medications are products you can purchase on your own and do not require a prescription from a doctor. OTC medications used to treat eczema include hydrocortisone, antihistamines and eczema-specific shampoos and washes, which you can find at a local drugstore.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/over-the-counter/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about OTC treatments for eczema.\u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EPrescription topicals\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ETopical medications for eczema are typically creams, gels and lotions that are applied to the skin to manage symptoms and reduce inflammation. These eczema creams include various steroids and nonsteroidals.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/topicals/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EGet the details on all the various topical treatments your doctor may prescribe for eczema.\u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EPrescription oral medications\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EThere are various pills available to treat eczema for adults. Oral medicines may include immunosuppressants and JAK inhibitors.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/oral-medications/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about prescription pills and oral treatments for eczema.\u003C/span\u003E\u003C/i\u003E \u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EPrescription injectables\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EThere\u003C/span\u003E \u003Cspan style=\u0022font-weight: 400;\u0022\u003Eare several medicines available to treat eczema that are given by injection or needle. These are some of the newer medications for eczema, they are called biologics. There are several biologics now on the market. Steroids can also be given by injection, but this is not very common nowadays and is used in very rare cases.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/injectables/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about biologics given by injection for eczema.\u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EAlternative and complementary treatments\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EMany people with eczema turn to alternative and complementary methods to help manage eczema symptoms like traditional Chinese medicine and Ayurveda. These are typically treatments that are based in Eastern medicine practices or more naturopathic therapies. The phrase “alternative treatment” refers to a patient using Eastern or naturopathic treatments in place of conventional Western medicine. The phrase “complementary treatment” refers to a patient using both Western and Eastern medicine together to treat a condition. \u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/complementary-alternative/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about alternative and complementary treatments for eczema. \u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Cem\u003EMedically reviewed on May 8, 2025.\u003C/em\u003E\u003C/p\u003E","maxWidth":"","content":"\u003Cdiv class=\u0022gaiopx gaiopx-7\u0022\u003E\u003Cdiv class=\u0022gaiopx-single aaiopx-33\u0022\u003E\u003Cdiv style=\u0022border-top:1px solid #dbd4c5;border-bottom:1px solid #dbd4c5;padding:10px 0 8px; margin-bottom:24px;text-align:center;\u0022\u003E\u003C!-- /22697575788/top_of_page --\u003E\r\n\u003Cdiv id=\u0027div-gpt-ad-1648775877115-0\u0027 style=\u0027min-width: 300px; min-height: 50px;\u0027\u003E\r\n \r\n\u003C/div\u003E\u003C/div\u003E\u003C/div\u003E\u003C/div\u003E\u003Ch2\u003ECurrent treatment options for eczema\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EIf you\u0026#8217;re seeking relief from eczema symptoms, you\u0026#8217;re not alone. Millions of people manage this chronic skin condition daily. While there\u0026#8217;s no cure, a variety of effective treatments can help you manage and prevent eczema flares. \u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EDepending on severity, managing eczema often involves a combination of lifestyle adjustments, daily management routines and medications to alleviate symptoms and prevent flares. These eczema treatments include: \u003C/span\u003E\u003C/p\u003E\u003Cdiv class=\u0022gaiopx gaiopx-8\u0022\u003E\u003Cdiv class=\u0022gaiopx-single aaiopx-35\u0022\u003E\u003Cdiv style=\u0022border-top:1px solid #dbd4c5;border-bottom:1px solid #dbd4c5;margin-bottom:20px;padding: 10px 0;text-align:center;\u0022\u003E\u003C!-- /22697575788/middle_of_page --\u003E\r\n\u003Cdiv id=\u0027div-gpt-ad-1651274528528-0\u0027 style=\u0027min-width: 300px; min-height: 50px;\u0027\u003E\r\n \r\n\u003C/div\u003E\u003C/div\u003E\u003C/div\u003E\u003C/div\u003E\n\u003Cul\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EBathing\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EMoisturizing\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EWet wrap therapy\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EPhototherapy\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EOver-the-counter medicines\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EPrescription topicals (creams, gels)\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EPrescription oral medicines (pills, liquid)\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EPrescription injectables (needle injections)\u003C/span\u003E\u003C/li\u003E\n\u003Cli style=\u0022font-weight: 400;\u0022 aria-level=\u00221\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EAlternative and complementary treatments \u003C/span\u003E\u003C/li\u003E\n\u003C/ul\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EThese are the go-to standard of care protocols for managing eczema that your doctor will discuss with you. By working with your healthcare provider, you can develop a treatment plan unique to you. Eczema affects everyone differently — what alleviates one person\u0026#8217;s symptoms might not work for another. Understanding your specific triggers and treatment responses is crucial. \u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about each treatment below and get more details about each one to help you understand your options.\u003C/span\u003E\u003C/p\u003E\n\u003Ch2\u003EBathing for eczema\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EPeople with eczema tend to have very dry skin in general. A skin barrier that is inflamed or dry is vulnerable to bacteria and allergens, which can make eczema symptoms worse. Taking a bath or shower is helpful for \u003C/span\u003E\u003Ca href=\u0022https://nationaleczema.org/types-of-eczema\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003Eeczema\u003C/span\u003E\u003C/a\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003E. It helps remove potential irritants from your skin (dust, pollen, etc.). Bathing with lukewarm water for a short period of time is recommended and immediately moisturizing after getting out of the shower or bath is a must to prevent drying out of the skin.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/bathing/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about bathing routines, oatmeal bath remedies, bleach bath treatments and more.\u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EMoisturizing for eczema\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EMoisturizers, including lotions, creams and ointments, help protect the outermost layer of skin known as the skin barrier. People with eczema have a damaged skin barrier, which makes their skin more sensitive to irritants and allergens. It’s important to understand how and when to properly moisturize and which products are best to use when you have eczema.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/moisturizing/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about the best moisturizing techniques to help manage eczema.\u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EWet wrap therapy\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EWet wrap therapy is a treatment for \u003C/span\u003E\u003Ca href=\u0022https://nationaleczema.org/types-of-eczema/\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003Eatopic dermatitis\u003C/span\u003E\u003C/a\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003E, the most common type of \u003C/span\u003E\u003Ca href=\u0022https://nationaleczema.org/eczema/\u0022\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003Eeczema\u003C/span\u003E\u003C/a\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003E. Doctors typically recommend wet wraps during severe eczema flares when there is severe pain or itch. Wet wrap therapy can help reduce itch and pain and provide some relief.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/wet-wrap-therapy/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about wet wraps for eczema, including how to do them and when you should use them.\u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EPhototherapy\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EPhototherapy, also called light therapy, is a treatment for eczema that uses specific wavelengths of ultraviolet (UV) light to reduce itch and inflammation. It is prescribed for various types of eczema but it is most often used for moderate to severe eczema.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/phototherapy/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about phototherapy, including how it works and what you can expect during a session.\u003C/span\u003E\u003C/i\u003E \u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EOver-the-counter medicines\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EOver-the-counter (OTC) medications are products you can purchase on your own and do not require a prescription from a doctor. OTC medications used to treat eczema include hydrocortisone, antihistamines and eczema-specific shampoos and washes, which you can find at a local drugstore.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/over-the-counter/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about OTC treatments for eczema.\u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EPrescription topicals\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ETopical medications for eczema are typically creams, gels and lotions that are applied to the skin to manage symptoms and reduce inflammation. These eczema creams include various steroids and nonsteroidals.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/topicals/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EGet the details on all the various topical treatments your doctor may prescribe for eczema.\u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EPrescription oral medications\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EThere are various pills available to treat eczema for adults. Oral medicines may include immunosuppressants and JAK inhibitors.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/oral-medications/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about prescription pills and oral treatments for eczema.\u003C/span\u003E\u003C/i\u003E \u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EPrescription injectables\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EThere\u003C/span\u003E \u003Cspan style=\u0022font-weight: 400;\u0022\u003Eare several medicines available to treat eczema that are given by injection or needle. These are some of the newer medications for eczema, they are called biologics. There are several biologics now on the market. Steroids can also be given by injection, but this is not very common nowadays and is used in very rare cases.\u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/injectables/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about biologics given by injection for eczema.\u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Ch2\u003EAlternative and complementary treatments\u003C/h2\u003E\n\u003Cp\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003EMany people with eczema turn to alternative and complementary methods to help manage eczema symptoms like traditional Chinese medicine and Ayurveda. These are typically treatments that are based in Eastern medicine practices or more naturopathic therapies. The phrase “alternative treatment” refers to a patient using Eastern or naturopathic treatments in place of conventional Western medicine. The phrase “complementary treatment” refers to a patient using both Western and Eastern medicine together to treat a condition. \u003C/span\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https://nationaleczema.org/treatments/complementary-alternative/\u0022\u003E\u003Ci\u003E\u003Cspan style=\u0022font-weight: 400;\u0022\u003ELearn more about alternative and complementary treatments for eczema. \u003C/span\u003E\u003C/i\u003E\u003C/a\u003E\u003C/p\u003E\n\u003Cp\u003E\u003Cem\u003EMedically reviewed on May 8, 2025.\u003C/em\u003E\u003C/p\u003E\n\u003Cdiv class=\u0022gaiopx gaiopx-6\u0022\u003E\u003Cdiv class=\u0022gaiopx-single aaiopx-34\u0022\u003E\u003Cdiv style=\u0022border-top:1px solid #dbd4c5; text-align:center;padding-top:30px; \u0022\u003E\u003C!-- /22697575788/bottom_of_page --\u003E\r\n\u003Cdiv id=\u0027div-gpt-ad-1648776332574-0\u0027 style=\u0027min-width: 300px; min-height: 50px;\u0027\u003E\r\n \r\n\u003C/div\u003E\u003C/div\u003E\u003C/div\u003E\u003C/div\u003E\u003C/p\u003E","scripts":["googletag.cmd.push(function() { googletag.display(\u0027div-gpt-ad-1648775877115-0\u0027); });","googletag.cmd.push(function() { googletag.display(\u0027div-gpt-ad-1651274528528-0\u0027); });","googletag.cmd.push(function() { googletag.display(\u0027div-gpt-ad-1648776332574-0\u0027); });"]}},{"name":"content-tabs","instance":1,"visibility":["lg","md","sm"],"config":{"title":"Read the latest prescription drug announcements","tabs":[{"text":"Latest press releases","cards":[{"title":"Dec. 13, 2024 Galderma","desc":"Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis","url":"https://nationaleczema.org/blog/press-release-galderma-nemolizumab-moderate-to-severe-atopic-dermatitis/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma.jpg 640w","alt":""}},{"title":"Dec. 10, 2024 Astria Therapeutics","desc":"Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0310, a Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis ","url":"https://nationaleczema.org/blog/astria-121024/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2025/05/astria-220x160.png","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2025/05/astria-220x160.png 220w,https://nationaleczema.org/wp-content/uploads/2025/05/astria-440x320.png 440w,https://nationaleczema.org/wp-content/uploads/2025/05/astria-320x190.png 320w,https://nationaleczema.org/wp-content/uploads/2025/05/astria-640x380.png 640w","alt":""}},{"title":"Sept. 24, 2024 Leo","desc":"FDA Accepts LEO Pharma’s Filing of Delgocitinib Cream New Drug Application for the Treatment of Chronic Hand Eczema","url":"https://nationaleczema.org/blog/press-release-leo-pharma-delgocitinib-chronic-hand-eczema/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Leo-220x160.png","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Leo-220x160.png 220w,https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Leo-440x320.png 440w,https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Leo-320x190.png 320w,https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Leo.png 640w","alt":""}},{"title":"Sept. 16, 2024 Lilly","desc":"FDA Approves Lilly’s EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis","url":"https://nationaleczema.org/blog/press-release-lilly-ebglyss-atopic-dermatitis/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_LillySmall-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_LillySmall-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_LillySmall-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_LillySmall-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_LillySmall.jpg 640w","alt":""}},{"title":"Jul. 10, 2024 Arcutis Biotherapeutics","desc":"FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age","url":"https://nationaleczema.org/blog/press-release-arcutis-zoryve-atopic-dermatitis/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis.jpg 640w","alt":"Arcutis logo"}},{"title":"May 3, 2024 Dermavant","desc":"Dermavant Announces FDA Acceptance of Supplemental New Drug Application (sNDA) for VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older","url":"https://nationaleczema.org/blog/dermavant-042924/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant.jpg 640w","alt":""}},{"title":"Mar. 14, 2024 Lilly","desc":"More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study","url":"https://nationaleczema.org/blog/lilly-031024/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_LillySmall-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_LillySmall-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_LillySmall-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_LillySmall-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_LillySmall.jpg 640w","alt":""}},{"title":"Feb. 16, 2024 Galderma","desc":"Galderma announces regulatory filing acceptance for nemolizumab in prurigo nodularis and atopic dermatitis in the U.S. and EU","url":"https://nationaleczema.org/blog/galderma-021424/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma.jpg 640w","alt":""}},{"title":"Dec. 15, 2023 Arcutis Biotherapeutics","desc":"FDA Approves Arcutis’ ZORYVE® (roflumilast) Topical Foam, 0.3% for the Treatment of Seborrheic Dermatitis in Individuals Aged 9 Years and Older","url":"https://nationaleczema.org/blog/arcutis-121523/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis.jpg 640w","alt":"Arcutis logo"}},{"title":"Dec. 15, 2023 Leo","desc":"LEO Pharma Inc. Announces U.S. FDA approval of Adbry® (tralokinumab-ldrm) for the Treatment of Moderate-to-severe Atopic Dermatitis in Pediatric Patients Aged 12-17 Years","url":"https://nationaleczema.org/blog/leo-121523/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Leo-220x160.png","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Leo-220x160.png 220w,https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Leo-440x320.png 440w,https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Leo-320x190.png 320w,https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Leo.png 640w","alt":""}},{"title":"Nov. 30, 2023 Arcutis Biotherapeutics","desc":"FDA Accepts Arcutis’ Supplemental New Drug Application for Roflumilast Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to Age 6","url":"https://nationaleczema.org/blog/arcutis-112923/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis.jpg 640w","alt":"Arcutis logo"}},{"title":"Oct. 16, 2023 Sanofi","desc":"Late-breaking amlitelimab Phase 2b data presented at EADV show potential best-in-class profile in atopic dermatitis","url":"https://nationaleczema.org/blog/sanofi-101323/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2023/10/Sanofi-logo-scaled-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2023/10/Sanofi-logo-scaled-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2023/10/Sanofi-logo-scaled-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2023/10/Sanofi-logo-scaled-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2023/10/Sanofi-logo-scaled-640x380.jpg 640w","alt":""}},{"title":"Oct. 16, 2023 Aslan Pharaceuticals","desc":"ASLAN Pharmaceuticals Presents New Data From Phase 2b Study of Eblasakimab in Atopic Dermatitis in Late Breaker Presentation at 32nd European Academy of Dermatology and Venereology Congress","url":"https://nationaleczema.org/blog/aslan-101323/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2022/02/Aslan_Logo_680x340-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2022/02/Aslan_Logo_680x340-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2022/02/Aslan_Logo_680x340-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2022/02/Aslan_Logo_680x340-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2022/02/Aslan_Logo_680x340.jpg 640w","alt":""}},{"title":"Oct. 16, 2023 Dermavant","desc":"Dermavant Announces New Positive Pruritus Data for VTAMA®(tapinarof) Cream, 1% in Adults and Children as Young as Two Years Old with Atopic Dermatitis at the EADV Congress 2023\n","url":"https://nationaleczema.org/blog/dermavant-101223/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant.jpg 640w","alt":""}},{"title":"Oct. 16, 2023 Galderma","desc":"Galderma @ EADV 2023: phase III trials demonstrate nemolizumab’s efficacy and rapid onset of action in atopic dermatitis and prurigo nodularis","url":"https://nationaleczema.org/blog/galderma-101123/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2021/05/Website_NewTreatments_PressReleases_Galderma.jpg 640w","alt":""}},{"title":"Oct. 16, 2023 Lilly","desc":"U.S. Food and Drug Administration Issues Complete Response Letter for Lebrikizumab Based on Inspection Findings at Third-Party Manufacturer","url":"https://nationaleczema.org/blog/lilly-10223/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Lilly-220x160.png","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Lilly-220x160.png 220w,https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Lilly-440x320.png 440w,https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Lilly-320x190.png 320w,https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Lilly.png 640w","alt":""}},{"title":"Oct. 16, 2023 Arcutis Biotherapeutics","desc":"Arcutis Submits Roflumilast Cream 0.15% Supplemental New Drug Application to the FDA for the Treatment of Atopic Dermatitis in Adults and Children Ages 6 Years and Older","url":"https://nationaleczema.org/blog/arcutis-91223/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis.jpg 640w","alt":"Arcutis logo"}},{"title":"May 23, 2023 Dermavant","desc":"Dermavant Reports Positive Topline Results from ADORING 1, the Second Atopic Dermatitis Phase 3 Trial of VTAMA® (tapinarof) Cream, 1% in Adults and Children as Young as 2 Years Old","url":"https://nationaleczema.org/blog/dermavant-51623/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2020/09/Website_EAM_PageHeroFeed_PartnerAssets_Dermavant.jpg 640w","alt":""}},{"title":"May 23, 2023 Arcutis Biotherapeutics","desc":"Arcutis Announces FDA Acceptance of New Drug Application for Roflumilast Foam 0.3% for the Treatment of Seborrheic Dermatitis in Individuals Aged 9 Years and Older","url":"https://nationaleczema.org/blog/arcutis-41823/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-220x160.jpg","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-220x160.jpg 220w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-440x320.jpg 440w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis-320x190.jpg 320w,https://nationaleczema.org/wp-content/uploads/2022/09/Website_NewTreatments_PressReleases_Arcutis.jpg 640w","alt":"Arcutis logo"}},{"title":"Feb. 11, 2023 Pfizer","desc":"FDA Approves Pfizer’s Supplemental New Drug Application for CIBINQO® (abrocitinib)","url":"https://nationaleczema.org/blog/pfizer-21023/","image":{"src":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Pfizer-220x160.png","width":220,"height":160,"srcset":"https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Pfizer-220x160.png 220w,https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Pfizer-440x320.png 440w,https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Pfizer-320x190.png 320w,https://nationaleczema.org/wp-content/uploads/2021/04/Website_NewTreatments_PressReleases_Pfizer.png 640w","alt":""}}]}]}},{"name":"image-text","instance":1,"visibility":["lg","md","sm"],"config":{"title":"Drug FAQ ","desc":"Get the details on the latest prescription drugs approved for eczema. Learn how each drug works, who can take it, effectiveness, side effects and more.","button_type":"link","button_text":"View drug FAQ","button_url":"https://nationaleczema.org/treatments/drug-faq/","image_placement":"right","image_data":{"src":"https://nationaleczema.org/wp-content/uploads/2022/06/doctor-holding-white-bottle-of-pills-378x340.jpg","srcset":"https://nationaleczema.org/wp-content/uploads/2022/06/doctor-holding-white-bottle-of-pills-378x340.jpg 378w,https://nationaleczema.org/wp-content/uploads/2022/06/doctor-holding-white-bottle-of-pills-756x540.jpg 756w,https://nationaleczema.org/wp-content/uploads/2022/06/doctor-holding-white-bottle-of-pills-745x470.jpg 745w,https://nationaleczema.org/wp-content/uploads/2022/06/doctor-holding-white-bottle-of-pills.jpg 960w","width":378,"height":340,"alt":"doctor holding white bottle of pills"}}}]

Get the latest eczema news delivered to your inbox.